Destiny Pharma (DEST)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

115.50p
   
  • Change Today:
    -3.00p
  • 52 Week High: 187.00
  • 52 Week Low: 54.79
  • Currency: UK Pounds
  • Shares Issued: 59.86m
  • Volume: 10,002
  • Market Cap: 69.14m
  • RiskGrade: 410

Destiny Pharma Overview

Destiny Pharma, a clinical stage biotechnology company focused on the development of novel anti-microbial drugs, which address the global problem of anti-microbial resistance (AMR).

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 5.7  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Destiny Pharma Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-16 n/a (1.45) (3.98)p n/a n/a n/a n/a 0.0%
31-Dec-17 n/a (3.21) (8.37)p n/a n/a n/a n/a 0.0%
31-Dec-18 n/a (6.01) (11.85)p n/a n/a n/a n/a 0.0%
31-Dec-19 n/a (5.52) (10.66)p n/a n/a n/a n/a 0.0%
31-Dec-20 n/a (6.48) (12.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Destiny Pharma Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 n/a (6.56) (8.84)p n/a n/a n/a n/a 0.0%
31-Dec-22 n/a n/a n/a n/a n/a n/a n/a 0.0%

Copyright © 2021 FactSet Research Systems Inc. All rights reserved.

Destiny Pharma Company Announcements

Interim results for six months ended 30 June 2021 09-Sep-2021 07:00 RNS
Notice of Interim Results 23-Aug-2021 07:00 RNS
Secondary endpoint analysis from Phase 2b trial 02-Aug-2021 07:00 RNS

Latest Destiny Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Destiny Pharma Market Data

Currency UK Pounds
Share Price 115.50p
Change Today -3.00p
% Change -2.53 %
52 Week High 187.00
52 Week Low 54.79
Volume 10,002
Shares Issued 59.86m
Market Cap 69.14m
RiskGrade 410

Destiny Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
41.81% below the market average41.81% below the market average41.81% below the market average41.81% below the market average41.81% below the market average
16% below the sector average16% below the sector average16% below the sector average16% below the sector average16% below the sector average
Price Trend
41.25% above the market average41.25% above the market average41.25% above the market average41.25% above the market average41.25% above the market average
32.26% above the sector average32.26% above the sector average32.26% above the sector average32.26% above the sector average32.26% above the sector average
Income Not Available
Growth Not Available

Destiny Pharma Dividends

No dividends found

Trades for 20-Sep-2021

Time Volume / Share Price
10:28 4,000 @ 113.00p
10:24 15 @ 120.00p
10:24 1 @ 120.00p
10:24 1,282 @ 117.00p
09:35 4,284 @ 117.00p

Destiny Pharma Key Personnel

CEO Neil Clark
Chair Nick Rodgers

Top of Page